67 related articles for article (PubMed ID: 1036951)
1. Cardiovascular effects of an antiarrhythmic aminosteroid ORG 6001 in the anesthetized pig.
Verdouw PD; Remme WJ; Beaune J; Rutteman AM; Hagemeijer F
Arzneimittelforschung; 1976; 26(8):1558-61. PubMed ID: 1036951
[TBL] [Abstract][Full Text] [Related]
2. Antiarrhythmic, metabolic and hemodynamic effects of Org 6001 (3alpha-amino-5alpha-androstan-2beta-ol-17-one-hydrochloride) after coronary flow reduction in pigs.
Verdouw PD; Schamhardt HC; Remme WJ; De Jong JW
J Pharmacol Exp Ther; 1978 Mar; 204(3):634-44. PubMed ID: 633069
[TBL] [Abstract][Full Text] [Related]
3. Antiarrhythmic and hemodynamic effects of an aminosteroid (Org 3001) in the digitalized dog.
Remme WJ; Verdouw PD; Hagemeyer F
Eur J Pharmacol; 1976 Mar; 36(1):189-97. PubMed ID: 1261591
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular effects of aprindine, a new antiarrhythmic drug.
Remme WJ; Verdouw PD
Eur J Cardiol; 1975 Dec; 3(4):307-13. PubMed ID: 1193115
[TBL] [Abstract][Full Text] [Related]
5. ORG 6001 (3alpha-amino-5alpha-androstan-2beta-ol-17-one hydrochloride), a steroidal anti-arrhythmic agent.
Vargaftig BB; Sugrue MF; Buckett WR; van Riezen H
J Pharm Pharmacol; 1975 Sep; 27(9):697-9. PubMed ID: 241815
[No Abstract] [Full Text] [Related]
6. General pharmacological studies on N-(2,6-dimethylphenyl)-8-pyrrolizidineacetamide hydrochloride hemihydrate. 3rd communication: effect on cardiovascular system.
Aisaka K; Hidaka T; Hattori Y; Inomata N; Ishihara T; Satoh F
Arzneimittelforschung; 1988 Oct; 38(10):1417-25. PubMed ID: 3196382
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular effects of (2RS,3SR)- 2-aminomethyl-2,3,7,8-tetrahydro-2,3,5,8,8-pentamethyl-6H-furo- [2,3-e]indol-7-one hydrochloride (UK-1745), a novel cardiotonic agent with vasodilatory and antiarrhythmic properties.
Uchida Y; Kawada M; Sawanobori K; Sonoki H; Inoue K; Mizuno K; Itou T; Tabunoki Y; Tsukamoto M; Ohashi Y; Kyotani Y; Shimizu N; Fujii M; Nakamura M
Arzneimittelforschung; 1998 Mar; 48(3):219-31. PubMed ID: 9553677
[TBL] [Abstract][Full Text] [Related]
8. Hemodynamic effects of antiarrhythmic drugs in acute myocardial infarction.
Lotto A; Finzi A; Massari FM; Pagnoni F; Valentini R; Ambrosini F; Lo Masto M
G Ital Cardiol; 1984 Oct; 14(10):762-7. PubMed ID: 6519385
[TBL] [Abstract][Full Text] [Related]
9. The antiarrhythmic and hemodynamic actions of alpha, alpha-dimethyl-4-(alpha, alpha, beta, beta-tetrafluorophenethyl) benzylamine (MK-251).
Torchiana ML; Stone CA; Wenger HC; Evans R; Lagerquist B; O'Malley T
J Pharmacol Exp Ther; 1975 Aug; 194(2):415-26. PubMed ID: 1151767
[TBL] [Abstract][Full Text] [Related]
10. Antiarrhythmic, haemodynamic and metabolic effects of 3alpha-amino-5alpha-androstan-2beta-ol-17-one hydrochloride in greyhounds following acute coronary artery ligation.
Marshall RJ; Parratt JR
Br J Pharmacol; 1975 Nov; 55(3):359-68. PubMed ID: 1133
[TBL] [Abstract][Full Text] [Related]
11. Antiarrhythmic, electrophysiologic and hemodynamic effects of ACC-9358.
Brown BS; Calzadilla SV; Diemer MJ; Hartman JC; Reynolds RD
J Pharmacol Exp Ther; 1987 Dec; 243(3):1225-34. PubMed ID: 3694532
[TBL] [Abstract][Full Text] [Related]
12. Comparative cardiovascular effects of verapamil, nifedipine, and diltiazem during halothane anesthesia in swine.
Kates RA; Zaggy AP; Norfleet EA; Heath KR
Anesthesiology; 1984 Jul; 61(1):10-8. PubMed ID: 6742468
[TBL] [Abstract][Full Text] [Related]
13. Local anaesthetic and antiarrhythmic properties of an aminosteroid: 3alpha-dimethyl-amino-5alpha-androstan-2beta-ol-17-one (Org. NA 13).
Buckett WR; Marwick FA
Br J Pharmacol; 1975 May; 54(1):3-9. PubMed ID: 1139075
[TBL] [Abstract][Full Text] [Related]
14. [Modification of hemodynamics by intravenous administration of flecainide].
Hoffmeister HM; Hepp A; Seipel L
Z Kardiol; 1986 Mar; 75(3):176-81. PubMed ID: 3705689
[TBL] [Abstract][Full Text] [Related]
15. [The cardiovascular effect of Cordemcura on various animal models in vivo].
Rohde E; Muschick P; Modersohn D; Landmann H; Löwe H
Pharmazie; 1986 Mar; 41(3):194-5. PubMed ID: 3714794
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological studies on 3-[gamma-(p-fluorobenzoyl)propyl]-2,3,4,4a,5,6-hexahydro-1 (H)-pyrazino(1,2-a) quinoline hydrochloride (compound 69/183). Part II: Effect on cardiac dynamics.
Srimal RC; Mason DF; Dhawan BN
Arzneimittelforschung; 1978; 28(7):1092-5. PubMed ID: 582695
[TBL] [Abstract][Full Text] [Related]
17. [Effects of glucagon on systemic circulation, coronary blood flow and myocardial oxygen consumption in the anesthetized dog (author's transl)].
Tarnow J; Gethmann JW; Patschke D; Weymar A; Eberlein HJ
Arzneimittelforschung; 1975; 25(12):1906-10. PubMed ID: 1243661
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular effects of vasopressors in isoflurane-anesthetized dogs before and after hemorrhage.
Curtis MB; Bednarski RM; Majors L
Am J Vet Res; 1989 Nov; 50(11):1866-71. PubMed ID: 2619117
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular and neuromuscular effects of Org NC 45, pancuronium, metocurine, and d-tubocurarine in dogs.
Booij LH; Edwards RP; Sohn YJ; Miller RD
Anesth Analg; 1980 Jan; 59(1):26-30. PubMed ID: 7188662
[TBL] [Abstract][Full Text] [Related]
20. Assessment of the electrophysiologic, antiarrhythmic and haemodynamic profile of a new isoquinolinedione derivative.
Gülker H; Spyra W; Thale J; Krimphove F; Hübner A; Bender F
Arzneimittelforschung; 1987 Aug; 37(8):917-9. PubMed ID: 3675686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
